e-learning
resources
Berlin 2008
Wednesday, 08.10.2008
Interferon-gamma methods for the diagnosis of tuberculosis infection and disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical utility of the quantiFERON TB-2G test for elderly patients with active tuberculosis
Y. Kobashi, K. Mouri, Y. Obase, N. Miyashita, M. Oka (Kurashiki city, Japan)
Source:
Annual Congress 2008 - Interferon-gamma methods for the diagnosis of tuberculosis infection and disease
Session:
Interferon-gamma methods for the diagnosis of tuberculosis infection and disease
Session type:
Oral Presentation
Number:
4579
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Kobashi, K. Mouri, Y. Obase, N. Miyashita, M. Oka (Kurashiki city, Japan). Clinical utility of the quantiFERON TB-2G test for elderly patients with active tuberculosis. Eur Respir J 2008; 32: Suppl. 52, 4579
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Clinical evaluation of QuantiFERON TB-2G test for patients with active tuberculosis disease stratified by age groups
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009
Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients
Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease
Year: 2007
Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients
Source: Eur Respir J 2007; 30: 945-950
Year: 2007
Clinical evaluation of QuantiFERON TB -2g test in patients with nontuberculous mycobacterial disease
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009
Indeterminate results of QuantiFERON TB-2G test performed in routine clinical practice
Source: Eur Respir J 2009; 33: 812-815
Year: 2009
Clinical evaluation of a diagnostic method of tuberculosis infection, QuantiFERON TB-2G, for active tuberculosis and nontuberculous mycobacteriosis
Source: Eur Respir J 2006; 28: Suppl. 50, 139s
Year: 2006
Assessment of the clinical utility of amplicor mycobacterium tuberculosis direct test during bacteriological confirmation of tuberculosis in children
Source: Annual Congress 2008 - Specific tuberculosis management problems in children and adolescents
Year: 2008
Usefulness of the QuantiFERON TB-2G test for the differential diagnosis of pulmonary tuberculosis
Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease
Year: 2007
Indeterminate results of quantiFERON TB-2G test performed in routine clinical practice
Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease
Year: 2008
Clinical and demographic characteristics of the tuberculin skin test positive patients without active tuberculosis contact
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Year: 2013
Diagnostic efficiency Diaskintest and Quantiferon test in comparison with the Mantoux test for active tuberculosis in children in Belarus
Source: International Congress 2019 – Paediatric tuberculosis
Year: 2019
Usefulness of a daignostic method of tuberculosis infection, QuantiFERON TB-2G, in a contact investigation of medical staffs
Source: Eur Respir J 2006; 28: Suppl. 50, 139s
Year: 2006
Experience of skin test application using tuberculosis recombinant allergen (Diaskintest) in tuberculosis diagnostics of children
Source: International Congress 2015 – Biomarkers in TB: immunology and physiology
Year: 2015
Sensitivity and specificity of new skin test with recombinant protein CFP10-ESAT6 in patients with tuberculosis and individuals with non- tuberculosis diseases
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013
Diagnosis of latent tuberculosis infection (LTBI) by quantiFERON®-TB gold test – QFT in homeless people in Poland
Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease
Year: 2008
Comparison of tuberculin test and Diaskintest® in the diagnosis of tuberculosis in children
Source: Annual Congress 2013 –Diagnostic features of tuberculosis II
Year: 2013
The diagnosis value of QuantiFERON-TB gold test at patients with active tuberculosis
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009
Evaluation of QuantiFERON TB test (QFT-TB) in detection of children infected with mycobacterium tuberculosis
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009
Clinical management of LTBI (PDF)// IGRAs for the diagnosis of tuberculosis (PPT)
Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination
Year: 2012
Audit on the use of T spot test in the diagnosis of active tuberculosis in UHCW
Source: Annual Congress 2009 - Clinical immunology of tuberculosis
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept